A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests - Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris - can help doctors make better decisions ...

The family of Terry Summerfield said he made a "lasting impression on everyone". Our thoughts are with them and all those who ...

A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...

Prostate health is an essential aspect of male well-being, yet many men avoid discussing it—until the symptoms become too ...

The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...

An innovative new drug being trialled to tackle certain cancers could also benefit patients with advanced prostate cancer whose treatment has stopped working, according to scientists. Experts ...

Prostate cancer imaging developed by university researchers has shown "extremely encouraging" results in its first clinical trials. A team at Heriot-Watt University leading the clinical trial said ...

INDIANAPOLIS — New research from the IU School of Medicine found a discovery that could lead to new treatments for prostate cancer. The American Cancer Society said one in eight men will be ...

Aggressive prostate cancer (PCa) variants associated with androgen receptor signaling inhibitor (ARSI) resistance and metastasis remain poorly understood. Here, we identify the axon guidance ...

Conservative MP Luc Berthold announced on Sunday that he has prostate cancer but still plans to run in the next federal election, despite requiring an operation. The longtime member of Parliament ...

As winter arrives, it’s vital for men, particularly those over 60, to pay attention to their prostate health. Dr. Raghavendra Kulkarni, Consultant Urologist at the Asian Institute of Nephrology ...